Paul Tudor Jones's MED Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 76,031 shares of Medifast, Inc. (MED) worth $806,689, representing 0.00% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 25 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in MED, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 76,031 shares. Largest reduction occurred in Q3 2024, reducing 47,954 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Medifast (MED) Holding Value Over Time
Track share changes against reported price movement
Quarterly Medifast (MED) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +76,031 | New Buy | 76,031 | $10.61 |
| Q3 2024 | -47,954 | Sold Out | 0 | $0.00 |
| Q2 2024 | +47,954 | New Buy | 47,954 | $21.82 |
| Q2 2023 | -2,789 | Sold Out | 0 | $0.00 |
| Q1 2023 | +2,789 | New Buy | 2,789 | $0.10 |
| Q3 2021 | -4,868 | Sold Out | 0 | $0.00 |
| Q2 2021 | +4,868 | New Buy | 4,868 | $283.07 |
| Q1 2020 | -16,627 | Sold Out | 0 | $0.00 |
| Q4 2019 | -12,873 | Reduce 43.64% | 16,627 | $109.58 |
| Q3 2019 | -194 | Reduce 0.65% | 29,500 | $103.63 |
| Q2 2019 | +23,564 | Add 384.40% | 29,694 | $128.31 |
| Q1 2019 | +6,130 | New Buy | 6,130 | $127.57 |
| Q3 2018 | -4,355 | Sold Out | 0 | $0.00 |
| Q2 2018 | +1,806 | Add 70.85% | 4,355 | $160.05 |
| Q1 2018 | +2,549 | New Buy | 2,549 | $93.37 |
| Q2 2017 | -5,667 | Sold Out | 0 | $0.00 |
| Q1 2017 | -3,633 | Reduce 39.06% | 5,667 | $44.29 |
| Q4 2016 | +3,578 | Add 62.53% | 9,300 | $41.61 |
| Q3 2016 | -19,378 | Reduce 77.20% | 5,722 | $37.75 |
| Q2 2016 | +8,200 | Add 48.52% | 25,100 | $33.27 |
| Q1 2016 | +16,900 | New Buy | 16,900 | $30.18 |
| Q1 2014 | -9,600 | Sold Out | 0 | $0.00 |
| Q4 2013 | +9,600 | New Buy | 9,600 | $26.15 |
| Q3 2013 | -11,300 | Sold Out | 0 | $0.00 |
| Q2 2013 | +11,300 | Add 0.00% | 11,300 | $25.75 |
Paul Tudor Jones's Medifast Investment FAQs
Paul Tudor Jones first purchased Medifast, Inc. (MED) in Q2 2013, acquiring 11,300 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Medifast, Inc. (MED) for 25 quarters since Q2 2013.
Paul Tudor Jones's largest addition to Medifast, Inc. (MED) was in Q2 2026, adding 76,031 shares worth $806,689.
According to the latest 13F filing for Q2 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 76,031 shares of Medifast, Inc. (MED), valued at approximately $806,689.
As of the Q2 2026 filing, Medifast, Inc. (MED) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Medifast, Inc. (MED) was 76,031 shares, as reported at the end of Q2 2026.